Alzheimer's drug donanemab: what promising trial means for treatments. Reardon S. Nature 2023 May 4. doi: 10.1038/d41586-023-01537.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reardon S. Alzheimer's drug donanemab: what promising trial means for treatments. Nature 2023 May 4. doi: 10.1038/d41586-023-01537.
PMID: 37142723